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Abstract 
Folding of proteins entering the mammalian secretory pathway requires the insertion of the correct 
disulfides.  Disulfide formation involves both an oxidative pathway for their insertion and a reductive 
pathway to remove incorrectly formed disulfides.  Reduction of these disulfides is critical for correct 
folding and degradation of misfolded proteins.  Previously, we showed that the reductive pathway is 
driven by NADPH generated in the cytosol.  Here, by reconstituting the pathway using purified 
proteins and ER microsomal membranes, we demonstrate that the thioredoxin reductase system 
provides the minimal cytosolic components required for reducing proteins within the ER lumen.  In 
particular, saturation of the pathway and its protease sensitivity demonstrates the requirement for a 
membrane protein to shuttle electrons from the cytosol to the ER.  These results provide compelling 
evidence for the critical role of the cytosol in regulating ER redox homeostasis ensuring correct 
protein folding and facilitating the degradation of misfolded ER proteins.   
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Introduction 
Proteins entering the secretory pathway undergo several modifications that are unique to the ER 
including glycosylation and disulfide formation (Braakman & Bulleid, 2011).  The consequence of 
these modifications is often increased stability of the protein fold in preparation for secretion into the 
extracellular milieu.  Failure to fulfil the correct modification can lead to protein misfolding and 
disease (Wang & Kaufman, 2016).  Correct protein disulfide formation requires resident ER proteins 
to catalyse both disulfide formation and reduction (Ellgaard, Sevier et al., 2018).  Disulfide formation 
is catalysed primarily by Ero1 which oxidises members of the protein disulfide isomerase (PDI) 
family by coupling the reduction of oxygen to the introduction of a disulfide (Sevier, Qu et al., 2007).  
PDI then exchanges its disulfide with substrate proteins during and following their translocation into 
the ER lumen (Chen, Helenius et al., 1995).  During this process, disulfides may form that are not 
present in the final native structure (Jansens, van Duijn et al., 2002).  Such non-native disulfides need 
to be removed to allow correct folding or to facilitate protein degradation (Ushioda, Hoseki et al., 
2008).  Hence, there is a requirement for both an oxidative and reductive pathway in the ER to ensure 
correct, native disulfides are formed or for proteins to be targeted for degradation (Bulleid & Ellgaard, 
2011).  In addition to the reduction of structural disulfides, there is also a requirement for a reductive 
pathway to recycle enzymes such as methionine sulfoxide reductase (Cao, Mitchell et al., 2018), 
vitamin K epoxide reductase (Rishavy, Usubalieva et al., 2011), peroxiredoxin IV (Tavender, 
Springate et al., 2010) and formyl glycine generating enzyme (Dierks, Dickmanns et al., 2005) that 
contain active site thiols which become oxidised during catalysis.   
Despite our understanding of the various pathways to introduce disulfides, our knowledge of the 
reductive pathway is limited.  Members of the PDI family such as ERdj5 are likely to catalyse the 
initial stage in the reduction of non-native disulfides (Jessop, Chakravarthi et al., 2007, Oka, Pringle 
et al., 2013, Ushioda et al., 2008).  ERdj5 has a relatively low reduction potential making it an 
efficient reductase (Hagiwara, Maegawa et al., 2011).  ERdj5 is recruited to substrate proteins via its 
interaction with BiP (Cunnea, Miranda-Vizuete et al., 2003, Hagiwara et al., 2011, Oliver, van der 
Wal et al., 1997).  Following the reduction of substrates, the PDI reductases will become oxidised so 
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to maintain activity there is a requirement for their enzymatic reduction.  Within the cytosol, the main 
disulfide reductase, Trx1, is maintained in a reduced state by the action of cytosolic thioredoxin 
reductase (TrxR1) with potential contribution from both the glutathione reductase (GR) and 
glutaredoxin (Grx) pathways (Lillig & Holmgren, 2007).  Both the Trx1 and glutathione pathways 
require NADPH as ultimate electron donor to maintain their reductase activity within the cytosol.  
However, there are no known equivalent pathways present within the ER for the reduction of 
disulfides in the thioredoxin domains within the PDI family.  We recently showed that the 
regeneration of NADPH within the cytosol is required to ensure correct disulfide formation in the ER 
lumen (Poet, Oka et al., 2017) raising the possibility that the cytosolic reductive pathways are 
responsible for ensuring correct disulfide formation in the ER lumen.  How the reducing equivalents 
generated in the cytosol are transferred to the ER lumen remains unknown but a system for the 
transfer of such equivalents does exist in prokaryotes.  Here disulfide formation and reduction within 
the periplasmic space is catalysed by DsbA and DsbC, which are structurally homologous to Trx1 
(Kadokura, Katzen et al., 2003).  Disulfide formation is coupled to the electron transport chain via a 
membrane protein called DsbB, allowing de novo disulfide formation in the disulfide exchange 
protein DsbA.  To remove incorrectly oxidised periplasmic thiols, the cytosolic thioredoxin reductase 
(TrxR) pathway via thioredoxin (Trx) reduces the membrane protein DsbD which transfers electrons 
across the membrane to reduce DsbC that then catalyses disulfide reduction.   
A role for GSH in the reduction of protein thiols has previously been suggested based upon its role as 
a redox buffer (Chakravarthi, Jessop et al., 2006).  This role has been suggested to be required to 
maintain redox balance after large fluctuations in either reducing or oxidising conditions 
(Appenzeller-Herzog, Riemer et al., 2010, Jessop & Bulleid, 2004, Molteni, Fassio et al., 2004).  A 
recent report identifying Sec61 as a GSH transporter provides a possible route for its transfer into the 
ER (Ponsero, Igbaria et al., 2017).  However, its requirement for the formation of the correct 
disulfides in proteins is less clear.  Depletion of ER GSH either by inhibition of GSH synthase or by 
targeting GSH-degrading enzymes does not prevent correct disulfide formation in proteins containing 
complex disulfides such as tissue-type plasminogen activator or the LDL-receptor (Chakravarthi & 
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Bulleid, 2004, Tsunoda, Avezov et al., 2014).  The relative roles of the thioredoxin and GSH 
pathways in maintaining ER redox poise and reducing oxidised thiols remains an unanswered 
question (Bulleid & Ellgaard, 2011, Ellgaard et al., 2018).   
To evaluate the requirements for the reduction of disulfides within the ER we reconstituted the 
pathway using purified cytosolic components and microsomal vesicles or semi-permeabilised cells as 
a source of ER.  Using a redox sensitive GFP as a readout (van Lith, Tiwari et al., 2011) we 
established the minimum requirements for disulfide reduction and demonstrated that the transfer of 
reducing equivalents across the ER membrane requires a membrane protein.  In addition, we show 
that the resolution of non-native to native disulfides can be driven solely by the thioredoxin pathway.  
Our results highlight the similarity between the pathways for reduction of disulfides in the bacterial 
periplasm and the mammalian ER.   
 
Results 
The reduction of ER-localised disulfides requires an ER membrane component.   
To follow the reduction of disulfide bonds within the ER lumen, we created a HT1080 stable cell line 
expressing a version of roGFP that can act as a reporter of disulfide formation within the ER of 
mammalian cells.  To improve the folding and stability of roGFP we included the super-folder 
mutations as described previously (Hoseki, Oishi et al., 2016), but using an ER targeted roGFP1-iE 
rather than roGFP1-iL.  The resulting cell-line demonstrated bright ER-localised fluorescence that 
was responsive to changes in both oxidation and reduction making it an ideal reporter for changes in 
ER redox state (Fig. 1A, B).  In addition, there was an absence of light-induced fluorescence changes, 
an effect that compromised the use of the roGFP1-iL variant (van Lith et al., 2011).  The variant of 
roGFP was designated ER-SFGFP-iE.  We isolated microsomal vesicles from the ER-SFGFP1-iE 
cell-line and were able to follow changes to ER redox status over time using a plate reader (Fig. 1C).  
We established that the microsomes were sensitive to both reduction with DTT and oxidation with 
diamide so the reporter was neither fully oxidised nor reduced following isolation.  Reduction with 
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membrane-permeable DTT was rapid reaching completion within 10 min.  When the membrane 
impermeable reducing agent TCEP was added to ER-SFGFP-iE containing microsomes, reduction 
still occurred but much slower than if the microsomes were solubilised prior to TCEP addition (Fig. 
1D, blue vs black).  Reduction in intact microsomes did not reach completion unless detergent was 
added to solubilise the ER membrane (see from 35 min).  To ensure the TCEP was not directly 
reducing ER-SFGFP-iE, we carried out a similar experiment but used TCEP immobilised on agarose 
beads.  ER-SFGFP-iE was reduced significantly (p = 0.00001) by immobilised TCEP agarose beads 
but not by buffer preincubated with TCEP beads (p = 0.03) (Fig. 1E).  These results strongly suggest 
the indirect reduction of ER-SFGFP-iE by TCEP when the microsomal membrane is intact. 
The lack of full reduction of ER-SFGFP-iE by TCEP suggests that the reaction had reached 
saturation.  To evaluate this possibility further we determined the rate of reduction with a range of 
TCEP concentrations (Fig. 1F, G).  The results show that the rate of reduction does indeed reach 
saturation at concentrations of TCEP over 1 mM suggesting a facilitated process.  To show that TCEP 
can reduce ER-SFGFP-iE directly and fully we determined the rate of reduction with a range of TCEP 
concentrations after solubilising the ER membrane (Fig. 1H, I).  Under these conditions the rate did 
not reach saturation suggesting a diffusion limited process.  These results with the membrane 
impermeable reducing agent suggest the indirect reduction of an ER-localised disulfide mediated via 
an ER membrane component.   
The thioredoxin reduction pathway is sufficient to reduce ER localised proteins via a membrane 
protein 
To evaluate the cytosolic components required to ensure reduction of ER-localised disulfides, we 
attempted to reconstitute the pathway with purified components.  We reasoned that a source of 
NADPH would be required as well as TrxR1 and Trx1.  To ensure efficient recycling of NADPH we 
included glucose 6 phosphate (G6P) as well as G6P dehydrogenase.  To demonstrate that the system 
could maintain Trx1 in its reduced state we determined the redox status of purified Trx1 before and 
after incubation with the recycling system.  Redox status was evaluated following modification with 
4-acetamido-4’-malemidylstilbene-2,2’-disulfonic acid (AMS) which increases the protein mass 
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slowing its electrophoretic mobility.  Prior to incubation, Trx1 was present as a mixture of both 
reduced and oxidised protein (Fig. 2A, lane 1).  After incubation with TrxR1 and the NADPH 
recycling system Trx1 was fully reduced (lane 2).  When our ER-SFGFP-iE containing microsomes 
were incubated with the TrxR1 reduction system, roGFP became more reduced, an effect that was 
dependent upon the inclusion of Trx1 as no reduction occurred in the presence of TrxR1 and the 
NADPH recycling system alone (Fig. 2B, C-Trx)).  No reduction of roGFP was observed when active 
site mutants of Trx1 (CXXS or SXXS) were used in place of wild type protein (CXXC).  These 
results demonstrate that the minimal requirement for reduction of ER-localised roGFP is the 
thioredoxin reduction system and that disulfide exchange is mediated though the Trx1 CXXC active 
site motif.  As the reduction was Trx1-dependent which is membrane impermeable, it is highly likely 
that an ER membrane component is required to transfer the reducing equivalents from Trx1 to roGFP.   
The experiments with roGFP provide us with a useful way to follow reduction of a specific disulfide 
within the ER lumen by components added outside the vesicles, however, this protein is not normally 
present in the ER.  Hence, we evaluated the redox status of ERp57, a member of the PDI family, to 
determine whether the thioredoxin reduction system could also reduce an endogenous ER protein that 
has previously been shown to be required for the correct folding of glycoproteins (Jessop et al., 2007).   
We used the approach described with AMS (Jessop & Bulleid, 2004) to probe the redox status of 
ERp57 in semi-permeabilised (SP)-cells isolated from a cell-line stably transfected with V5-tagged 
ERp57 (Jessop et al., 2007).  Samples were either untreated, treated with the oxidising agent diamide, 
with the reducing agent DTT or with the non-membrane permeable TCEP (Fig. 3Ai, ii).  Treatment 
with NEM blocks any free thiols and subsequent reduction and alkylation with AMS reduces the 
mobility of the protein.  Proteins that contain disulfides in the original SP-cells will, therefore, have 
reduced mobility on SDS-PAGE.  Following this procedure, ERp57 in untreated SP-cells migrated as 
two species representing the oxidised and reduced forms by comparison with the diamide or DTT 
treated samples (lanes 1-3).  After incubation with TCEP most of the ER-localised ERp57 was 
reduced though not completely (lane 4), a result which mirrors the incomplete reduction of roGFP and 
demonstrates that TCEP can substitute for a cytosolic reduction system.   
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To evaluate the ability of the thioredoxin pathway to reduce ER-localised ERp57, we first fully 
oxidised SP-cells with diamide, removed diamide by re-isolating the SP-cells and incubated with 
either the complete TrxR1 reduction system, with just recombinant Trx1 or with the reduction system 
without Trx1 (Fig. 3Bi, ii).  Partial reduction of fully oxidised ERp57 occurred in the presence of the 
complete system (lane 3) but did not occur with just Trx1 alone (lane 4) indicating the requirement for 
the recycling system.  The reduction of ERp57 was dependent upon Trx1 (lane 5) as was the case with 
roGFP.  In addition, the active site mutants of Trx1 lacking one or both cysteines within the CXXC 
motif were unable to reduce ERp57 (Fig. 3Ci, ii, lanes 4 and 5).  These results demonstrate that ER-
localised ERp57 can be reduced following oxidation by the cytosolic reduction pathway and that this 
reduction is dependent upon thioredoxin.   
To further characterise the membrane component required for reduction, we carried out a proteinase K 
digestion of our SP-cells prior to assaying for ERp57 reduction (Fig. 3Di, ii).  We surmised that if a 
membrane protein was involved then the transfer of reducing equivalents across the membrane may 
be sensitive to proteolysis.  Proteinase K digestion prevented the reduction of oxidised ERp57 by the 
reconstituted reduction system (lane 4) suggesting the requirement for a membrane protein whose 
cytosolic domain is sensitive to digestion.  We also determined whether the reduction of ERp57 by 
TCEP was sensitive to proteinase K treatment of the SP-cells (Fig. 3Ei, ii).  TCEP was still able to 
reduce oxidised ERp57 (lane 4) suggesting that either the membrane protein involved can be reduced 
efficiently by TCEP without its protease sensitive cytosolic domain or that TCEP acts via a separate 
component than the thioredoxin-dependent pathway.   
The thioredoxin reduction pathway is sufficient to reduce non-native disulfides in nascent 
chains exposed to the ER lumen 
We previously demonstrated that non-native disulfides formed during the synthesis of β1-integrin 
require a cytosolic reductive pathway to ensure their isomerisation to the correct disulfides (Poet et 
al., 2017).  To evaluate the ability of our reconstituted pathway to isomerise non-native disulfides, we 
generated stalled translocation intermediates of a protein that forms non-native disulfides following in 
vitro translation in the presence of semi-permeabilised (SP) cells (Robinson, Kanemura et al., 2020).  
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By isolating SP-cells containing these intermediates we were then able to follow the rearrangement of 
disulfides post-translationally in the presence or absence of a TrxR1 reduction system (Fig. 4A).  We 
generated a stalled translocation intermediate of disintegrin domain of ADAM10 by translating an 
RNA transcript lacking a stop codon.  The length of the synthesised chain is sufficient to allow 
exposure of several cysteines in the ER lumen (Fig. 4B) that have the potential to form disulfides.  
Translations were performed using a rabbit reticulocyte lysate supplemented with SP-cells to study 
folding in the ER (Wilson, Allen et al., 1995).  All samples were treated with NEM on completion to 
irreversibly modify thiols and freeze the disulfide status of the samples for downstream processing.  
When translations were carried out in the presence of a reducing agent (DTT) and the samples 
separated under non-reducing conditions, two products of approximately 18 and 20 kDa were 
synthesised (Fig. 4C, lane 1).  These products correspond to the translocated, signal sequence cleaved 
chain and untranslocated preprotein (Robinson et al., 2020).  When the translations were carried out in 
the absence of added G6P and a post-translational incubation carried out in the absence of G6P, a 
diffuse pattern emerged with the translation products forming both intra and inter-chain disulfides 
(lane 2).  When G6P was added post-translationally and samples incubated for 60 min, more distinct 
products were formed indicative of discrete disulfide-bonded species (lane 3).  When SP-cells were 
isolated from translations carried out in the absence of G6P and incubated in KHM buffer alone, no 
change to the banding pattern was observed (lane 4).  However, when the TrxR1 reduction system 
was added to the isolated SP-cells, rearrangement of disulfides was observed resulting in more distinct 
disulfide-bonded species (lane 5).  This change to the banding pattern to more discrete disulfide-
bonded species did not occur when the isolated SP-cells were incubated in the TrxR1 reductive 
pathway lacking Trx1 (lane 6).  We also demonstrated that TCEP could substitute for G6P when 
added to translations or to isolated SP-cells post-translationally giving rise to discrete disulfide-
bonded species (Fig. 4C, lanes 3 and 5).  We have previously shown that the disulfide-bonded 
products formed form this ADAM10 construct are present in nascent chains translocated into the ER 
lumen (Robinson et al., 2020).  Taken together these results show that a source of non-membrane 
permeable reducing agent can resolve the non-native disulfides formed in nascent chains within the 
ER lumen.   
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The thioredoxin reduction pathway reduces disulfides in several secretory and ER resident 
proteins 
The experiments with roGFP and ERp57 are dependent upon the reduction of a reversible disulfide 
that is solvent accessible in the final protein structure.  To determine whether our reconstituted 
reductive system could reduce other disulfides within secretory or membrane proteins, we carried out 
redox proteomics.  Essentially microsomes were incubated with the TrxR1 system in either the 
presence or absence of Trx1 for 60 min and reversibly oxidised thiol groups were labelled with heavy-
iodoacetamide.  The samples were prepared for LC/MS/MS analysis by trypsin digestion followed by 
tandem mass tagging to enable quantification of the changes in the cysteine oxidation levels between 
experimental conditions.  The resulting data was analysed by Perseus software and is presented as a 
volcano plot indicating the statistically significant changes to the reversibly oxidised cysteine residues 
upon incubation with Trx1 (Fig. 5A).  The redox status of several peptides changed during the 
incubation, specifically there was a subset of cysteines whose oxidised status decreased (more 
reduced) in the reactions containing Trx1, with the majority of the corresponding proteins being 
located in the ER lumen (blue circles).  Notably the regulatory cysteine (131) in Ero1α was reduced 
(Appenzeller-Herzog, Riemer et al., 2008, Baker, Chakravarthi et al., 2008) as was the cysteine 
involved in recycling VKORC1L1 (50) (Tie, Jin et al., 2014).  Changes to the redox status of a few 
cytosolic and mitochondrial proteins also occurred (orange circles), which likely co-purified with our 
microsomal vesicles.  The identity of all the proteins identified whose redox status changed along 
with their ultimate subcellular location is as illustrated (Fig. 5B) or detailed separately (Table 1).  The 
results demonstrate that several thiols within endogenous proteins that are synthesised at the ER, 
including thiols that form structural and regulatory disulfides, can be reduced by the thioredoxin 
reduction system.  The target proteins are localised to the ER lumen and the TrxR1 reduction system 
is membrane impermeable illustrating the requirement to transfer reducing equivalents across the 
membrane.    
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Discussion 
Our previous work provided the first indication that a cytosolic reductive pathway was required to 
ensure correct disulfide formation within the ER (Poet et al., 2017).  Here we demonstrate that the 
thioredoxin pathway is sufficient to provide the reducing equivalents to ensure the reduction of 
regulatory and non-native disulfides within ER proteins.  We have successfully reconstituted the 
reduction of ER disulfides using a microsomal system in the presence of purified components to 
demonstrate that the thioredoxin pathway can drive the reduction of disulfides in several ER-localised 
soluble and membrane proteins.  In addition, we show that the pathway is sufficient to facilitate the 
reduction of disulfides formed in nascent chains entering the ER lumen but does not prevent disulfide 
reformation – a requirement for correct isomerisation of non-native to native disulfides.  Importantly 
we show that a membrane protein is required to facilitate the transfer of reductant across the ER 
membrane, presumably via a disulfide exchange mechanism as demonstrated for the transfer of 
disulfides across the bacterial plasma membrane by DsbD (Cho, Porat et al., 2007).   
The absolute requirement for the presence of thioredoxin in our reconstituted system rules out a role 
for an NADPH-dependent ER-localised reductase.  Previously it has been postulated that an ER 
glutathione or thioredoxin reductase could utilise the ER pool of NADPH to drive the reduction of 
disulfides (Bulleid & Ellgaard, 2011).  As there is an ER-localised hexose 6-phosphate dehydrogenase 
(Lavery, Walker et al., 2006), G6P may enter the ER via the G6P-transporter, be metabolised to 
phosphogluconolactone and in the process regenerate the ER pool of NADPH.  Hence, the G6P effect 
we previously observed during our in vitro translations may be due to a process independent of the 
thioredoxin pathway.  This is clearly not the case for the reduction of roGFP, ERp57, disulfides in 
nascent chains and the range of proteins identified from the redox proteomics whose redox state 
change depended upon the presence of thioredoxin.   
The reductive pathway driven by cytosolic thioredoxin is versatile in terms of its target disulfides in 
the ER lumen.  These disulfides included those present within folded proteins such as roGFP, in 
proteins undergoing folding during translocation and in proteins that require reduction to maintain 
their activity.  Such versatility would suggest a broad substrate specificity of the terminal enzyme 
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involved in catalysing reduction.  Changes to the redox status of ERp57 would suggest that this 
member of the PDI family could act as a reductase as suggested previously for newly synthesised 
glycoproteins (Jessop et al., 2007) to which it is targeted via its interaction with calnexin or 
calreticulin (Oliver et al., 1997).  It is also likely that ERdj5 is reduced by the cytosolic reductive 
pathway and be targeted to substrate proteins through its interaction with BiP (Cunnea et al., 2003).  
Our identification of one of the regulatory disulfides within Ero1α (Baker et al., 2008) as a target for 
the cytosolic reductive pathway would suggest that this disulfide can be reduced by one of the PDI 
family members as demonstrated previously using purified proteins (Shepherd, Oka et al., 2014).  
Whether the ER membrane protein responsible for transfer of reducing equivalents directly reduces 
the PDI reductase remains to be established.   
The role of thioredoxin as reductant of the ER membrane protein can be replaced with the non-
membrane permeable reducing agent TCEP.  However, in contrast to thioredoxin-mediated process, 
reduction of ER proteins via TCEP was shown to be insensitive to protease digestion suggesting that 
this reagent can reduce the ER membrane protein in the absence of a protease sensitive cytosolic 
domain.  This result most likely reflects the different requirements for reduction of the membrane 
protein disulfide by thioredoxin and TCEP.  The mechanism underlying recognition and reduction of 
substrates by thioredoxin is not completely understood given its wide range of substrate specificity.  
However, it has been demonstrated that non-covalent interactions prior to disulfide reduction are 
important with recognition being due to the conformational restriction afforded by the oxidised 
substrate (Palde & Carroll, 2015).  Hence the proteolytic digestion of a protein domain or loop may 
prevent thioredoxin interacting with the membrane protein thereby inhibiting activity.  A chemical 
reductant such as TCEP would have no requirement for such non-covalent interactions and would 
only require the target disulfide to be solvent accessible.   
The identity of the membrane protein involved connecting the cytosolic thioredoxin couple with the 
ER remains unknown.  One resident ER membrane protein whose depletion leads to a more oxidising 
ER and a specific defect in correct disulfide formation in lipoprotein lipase is lipase maturation factor 
1 (LMF1) (Roberts, Babilonia-Rosa et al., 2018).  This protein contains several thiols in both its 
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cytosolic loops, transmembrane regions as well as its lumenal domain that are required for activity 
and could be involved in disulfide exchange.  Unfortunately, we did not identify LMF1 in our 
proteomics data, so we could not identify any changes to its redox status.  Hence, LMF1 remains a 
potential candidate to shuttle disulfides across the ER membrane.  Of the 41 microsomal proteins 
whose redox status changes during the incubation with the TrxR1 system, 4 are multi-pass membrane 
proteins with VKORC1L1 and GPAA1 being known resident ER proteins.  GPAA1 is a subunit of the 
GPI-anchor transamidase (Ohishi, Inoue et al., 2000) whereas VKORC1L1 is a paralogue of vitamin 
K epoxide hydrolase with a potential function in vitamin K-dependent carboxylation (Tie, Jin et al., 
2013).  Whether these proteins are directly involved in disulfide exchange across the ER membrane is 
a focus of future studies. 
 
Materials and Methods 
Generation of stable cell line expressing ER-SFGFP-iE – HT1080 cells were transfected with ER-
SFGFP-iE using MegaTran 1.0 (OriGene, Cambridge, UK) following the manufacturer’s protocol.  
Various dilutions (1:10 to 1:10,000) of transfected HT1080 cells were plated on 15 cm2 dishes.  Cells 
were grown in selective medium containing G418 (1mg/ml) until colonies appeared.  Single colonies 
were picked and transferred to 12 well plate (one colony per well) using trypsin-soaked Scienceware® 
cloning discs (Sigma. Dorset, UK).  Cells were grown until confluent and then transferred to 25 cm2 
flasks.  The presence of ER-SFGFP-iE was confirmed by western blot using rabbit anti-GFP antibody 
(Santa Cruz, California, USA cat# sc-8334, 1:200 dilution).  All cell lines are regularly tested for 
mycoplasma infection.   
Live cell microscopy and image analysis - HT1080 cells stably expressing ER-SFGFP-iE were seeded 
on coverslips.  The cells were washed with buffer (HEPES (20 mM) pH 7.4, NaCl (130 mM), KCl (5 
mM), CaCl2 (1 mM), MgCl2 (1 mM), D-glucose (10 mM)) before imaging on a Zeiss Axio Observer 
A1 inverted microscope equipped with a 40 x FLUAR lens (Zeiss, Oberkochon, Germany).  The cells 
were sequentially excited by 385 and 470 nm LEDs with fluorescence detection through a T495 lpxr 
beamsplitter (Chroma, Vermont, USA).  Images were captured at 30 s intervals and analysed with 
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AxioVision 4.8 software.  The 385/470 nm ratio images of untreated, diamide-treated (1 mM) and 
dithiothrietol (DTT)-treated (10 mM) cells were false-coloured using a rainbow look-up table.  The 
385/470 nm ratio changes over time were quantified by defining regions of interest for individual cells 
and plotted as the average ratio with standard deviation. 
Preparation of microsomal membranes 
Cells were cultured using cell culture roller bottles (1700 cm2) (Greiner Bio-one).  Confluent cells 
were detached from the roller bottle by incubation with 100 ml PBS containing EDTA (1 mM) for 15 
min.  Cells were pelleted, washed three times in HEPES–KOH (35 mM) buffer pH 7.5, containing 
NaCl (140 mM) and glucose (11 mM) followed by washing once in extraction buffer (HEPES–KOH 
(20 mM) pH 7.5, KOAc (135 mM), KCl (30 mM), and MgOAc(1.65 mM)).  An equal volume of 
extraction buffer to the cell volume was used for resuspension.  The cells were disrupted in a Mini-
Bomb Cell disruption chamber (KONTES) using a nitrogen pressure of 1.0 MPa for 30 min.  Cell 
homogenates were centrifuged at 6000 × g for 5 min at 4 oC and the post-nuclear supernatant was 
retained.  The supernatant was centrifuged at 50,000 × g (OptimaTM Max-XP Ultracentrifuge, 
Beckman Coulter) for 15 min at 4 oC to pellet the membrane fraction.  The membrane pellet was 
resuspended in buffer A (Tris-HCl (50 mM) pH7.4, sucrose (0.25 M), KCl (50 mM), MgOAc (6 
mM), EDTA (1 mM)) to give an A280 value of 50 units/µl (the absorbance was determined in water in 
the presence of 1% SDS).  Aliquots of the microsomal membranes were frozen in liquid nitrogen and 
stored at -80 °C.   
Measurement of changes to the redox state of microsomal ER-SFGFP-iE  
Microsomes were pipetted into Dulbecco's phosphate-buffered saline (PBS) (1.5 μl microsomes in 
48.5 µl PBS) in the absence or presence of 0.1% Triton X-100 (Thermo Fisher).  The solution was 
added into a CELLSTAR™ 96 Well Polystyrene Flat Bottom Cell Culture Microplate (Greiner Bio-
One) (final volume 50 μl/well) (three wells per condition).  Fluorescence intensities at 520 nm were 
measured following excitation at 390nm and 460 nm excitations wavelengths using PHERAstar® FS 
microplate reader (BMG LABTECH).  After 10 min measurement to obtain a baseline, DTT, diamide 
or different concentrations of Tris-(2-Carboxyethyl)phosphine (TCEP) (Thermo) were injected into 
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the wells.  Fluorescence intensities were recorded for up to 50 min.  In some experiments, the same 
amount of microsomes were untreated or treated with immobilized TCEP Disulfide Reducing Gel 
beads (Thermo) which has been washed twice with PBS to remove soluble TCEP or PBS that had 
been preincubated with TCEP beads for 60 min.  The samples were incubated for 60 min and then 
transferred into microplate wells to measure fluorescence intensity at 520 nm following excitation at 
390 and 460 nm excitation.   
To calculate the rate of change of the redox status of ER-SFGFP-iE at different TCEP concentrations, 
microsomes were treated with varied concentrations of TCEP in absence or presence of Triton X-100 
(0.1% v/v).  The fluorescence ratio (390nm/460nm) change was followed over time after addition of 
TCEP and the resulting time course fitted to an exponential decay function (y = -A(e-k(t-t0)-1) + c) to 
calculate the rate (k), where t0 = time of addition of TCEP, c = initial fluorescence ratio and A = 
difference in fluorescence ratio between t0 and t.  The rate was then plotted against the TCEP 
concentration.  The rate of reduction of ER-SFGFP-iE at different concentrations of TCEP was 
performed in triplicate. 
Recombinant protein purification 
Recombinant human thioredoxin (Trx1) wild-type and mutants were expressed and purified from 
Escherichia coli BL21-DE3 cells as described previously (Schwertassek, Balmer et al., 2007).  
Purification was by successive HisTrap affinity and size exclusion (Superdex 200 10/300) 
chromatography (GE Healthcare).  The protein concentration was determined following OD280nm 
measurement and calculated using an extinction coefficient of 12.49 mM-1cm-1.  The purified protein 
aliquots were flash frozen in liquid nitrogen and then stored -80 oC. 
Determining the redox state of Trx1 
Purified Trx (25 µM) was incubated in KHM buffer (HEPES (20 mM) buffer pH 7.2, including 
KOAc (110 mM), MgOAc (2 mM)) at 30 oC for 60 min in the absence or presence of NADPH (1 
mM), human TrxR1 (16.25 nM) (IMCO), G6P (1.25 mM) and G6PDH (10 U/ml).  The reaction was 
stopped by the addition of NEM (20 mM).  Samples were incubated with streptavidin agarose resin 
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(Thermo) in isolation buffer (Tris-HCl (50 mM) pH7.5, Triton (1%), NaCl (150 mM), EDTA (2 mM), 
PMSF (0.5 mM) and Na-azide (0.02%w/v)) at 4 oC for 60 min.  The streptavidin beads were pelleted 
by centrifugation and washed three times in isolation buffer to remove unbounded proteins.  Trx1 was 
eluted from the streptavidin beads by incubating at room temperature for 15 min with PBS including 
SDS (2 % w/v) and biotin (3 mM). The samples were boiled at 105 oC for 15 min and incubated with 
TCEP (10 mM) at room temperature for 10 min to break existing disulfides followed by a 1.5 h 
incubation with AMS (20 mM) (Invitrogen) in the dark to alkylate free thiols.  The samples were 
separated by SDS-PAGE and a Western blot performed using Streptavidin Protein DyLight 800 
(ThermoFisher, cat#21851, 1:5,000 dilution).   
Preparation of semi-permeabilised (SP) cells 
SP-cells were prepared as described previously (Wilson, Allen et al., 1995).  Following digitonin 
treatment, cells were resuspended in KHM buffer containing CaCl2 (1 mM) and treated with 
Stapylocossus aureus nuclease (Calbiochem) (150 U/ml) at room temperature for 12 min to remove 
the endogenous mRNA.  Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA, 
Sigma) (4.5 mM) was used to stop the reaction.  SP-cells were pelleted by centrifugation and 
resuspended in 100 µl KHM buffer to be used in translation reactions.  For ERp57 redox state 
determination experiments, SP-cells were prepared from cells expressing V5-tagged ERp57 (Jessop et 
al., 2007) and nuclease treatment was not included during the preparation.   
Determining the redox state of ER-localised ERp57 
The redox state of ERp57 in SP-cells was determined as described previously (Jessop & Bulleid, 
2004).  SP-cells were either untreated or treated with diamide (10 mM) at room temperature for 10 
min.  Samples were washed twice with 500 µl KHM buffer to remove diamide.  Oxidised SP cells 
were incubated at 30 oC for 60 min in KHM buffer with or without DTT or with the purified reductive 
pathway components NADPH (1 mM), human Trx1 (25 µM), human TrxR1 (16.25 nM), G6P (1.25 
mM), G6PDH (10 U/ml).  The SP cells were pelleted by centrifugation at 14,800 × g for 1 min and 
then incubated with 500 µl PBS containing 25 mM NEM to block free thiols.  The samples were 
washed twice using PBS (1 ml) to remove excess NEM.  The cells were lysed on ice with lysis buffer 
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(Tris-HCl (50 mM) containing NaCl (150 mM), EDTA (2 mM), PMSF (0.5 mM), and Triton X-100 
(1% v/v)) for 10 min. The lysate was centrifuged at 14,800 × g at 4oC for 10 min.  The supernatant 
was removed and boiled with SDS (2% (w/v)) (VWR chemicals) to denature the protein.  Denatured 
samples were incubated at RT with TCEP (10 mM) to break existing disulfide bonds followed by a 
1.5 h incubation with 4-acetamido-4’-maleimidylstilbene-2, 2’-disulfonic acid (20 mM) (AMS) 
(Invitrogen) in the dark.  The samples were separated by SDS-PAGE and a western blot performed 
with antibody to V5-tag to detect different redox state of ERp57. 
Western blotting 
Following SDS-PAGE, proteins were transferred to nitrocellulose blotting membrane (GE 
Healthcare).  The membrane was blocked with 3% w/v dried skimmed milk (Marvel) in TBST buffer 
(Tris-HCl pH 8.0 (150 mM), NaCl (150 mM), Tween-20 (0.5% v/v)) for 1 h.  The membrane was 
incubated in TBST including V5-antibody (Invitrogen, cat#R960-25, 1:10,000 dilution) for 1 h.  After 
primary antibody incubation, the membrane was incubated in 5 ml TBST with secondary antibody 
(Fisher Scientific, cat #10751195, 1:10,000 dilution) in the dark for 45-60 min.  The membrane was 
scanned by Li-Cor Odyssey 9260 Imager.  Quantification of gel intensity was by ImageJ (NIH, 
USA); experiments were carried out three times.  Values quoted are averages with error bars 
depicting standard deviation.   
Proteinase K treatment 
SP cells were incubated on ice with proteinase K (20 µg/ml) (Roche) for 25 min in the presence of 
CaCl2 (10 mM).  Proteinase K was inactivated by incubation with PMSF (0.5 mM).  Proteinase K and 
PMSF was removed by washing twice with KHM buffer.  
Preparation of ADAM10 domain construct and in vitro translation 
The human ADAM10 construct codes for residues 456-550 and contains the human-β2M signal 
sequence residues (1-20).  The generation of this construct and its transcription and translation were 
described previously (Robinson et al., 2020).  Essentially, plasmid DNA was used as a template for 
PCR using an appropriate forward primer that adds a T7 promoter and a reverse primer that lacks a 
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stop codon.  The PCR product was transcribed into an RNA template using T7 RNA polymerase.  
Translations were performed using the Flexi® Rabbit Reticulocyte Lysate System (Promega) 
supplemented with DTT (10 mM) or ddH20 but in the absence of added G6P.  SP-cells were added to 
a concentration of ∼105 cells per 25 μl translation reaction.  Following assembly of components, 
translation reactions were incubated at 30 °C for 15 min.  For post-translational assays, G6P (5 mM) 
was added following translation or SP-cells were isolated by centrifugation and resuspended in KHM 
buffer in the presence or absence of a TrxR1 reduction system NADPH (1 mM), human Trx1 (25 
µM), human TrxR1 (16.25 nM), G6P (1.25 mM) and G6PDH (1U) or TCEP (1 mM).  An additional 
incubation was carried out in the presence of the TrxR1 reduction system without Trx1.  The reactions 
were stopped after a 60 min incubation by the addition of NEM (final concentration 25 mM) prior 
immunoisolation, SDS-PAGE and phosphorimage analysis.  
Immunoisolation 
SP-cells from the translation reactions were resuspended in 1 ml immunoisolation buffer (IB) (Tris-
HCl (50 mM) pH7.5, Triton X-100 (1% v/v), NaCl (150 mM), EDTA (2 mM), PMSF (0.5 mM), Na-
azide (0.02 %)) containing 50 µl 10% Protein A Sepharose FF Resin (Generon).  After a 30 min 
incubation the beads were isolated by centrifugation at 16,000 xg for 30s. The supernatant was 
transferred into a new tube contained 50 µl 10% PAS.  Anti-V5 antibody (Invitrogen, cat #10751195, 
1 µl) was added and the suspension incubated at 4 oC overnight.  The beads were pelleted by 
centrifugation and washed three times wash using 1ml IB buffer.  The beads were heated for 5 min at 
105 oC with SDS-PAGE loading buffer (Tris/HCl (200 mM) pH 6.8, containing 10% v/v glycerol, 2% 
(w/v) SDS, 0.1 % (w/v) bromophenol blue).  The samples were separated by SDS-PAGE, the gels 
were fixed in 10% acetic acid and 10% methanol, dried and exposed to a phosphorimager plate.  A 
FLA-7000 bioimager (Fujifilm) was used to scan the plate to obtain the image. 
Sample preparation for mass spectrometry analysis 
Samples were prepared for redox proteomics as previously described (van der Reest, Lilla et al., 
2018) with some modifications.  Microsomes were incubated in the presence of the reductive system 
as described above either in the presence or absence of Trx1.  After 60 min incubation at 30 OC, 
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microsomes were lysed in a buffer containing 4% SDS, 50 mM triethylammonium bicarbonate pH 8.5 
and 55 mM unlabelled iodoacetamide (light IAA, 12C2H4INO – Sigma) to alkylate free cysteine thiols.  
For each experimental replicate, 30 µg of protein were subsequently labelled with stable-isotope 
labelled iodoacetamide (heavy IAA, 13C2D2H2INO, Sigma) to alkylate reversibly oxidised cysteines.  
Differentially alkylated proteins were precipitated using trichloroacetic acid (TCA) and digested first 
with Endoproteinase Lys-C (ratio 1:33 enzyme:lysate) for one h, followed by trypsin, overnight (ratio 
1:33 enzyme:lysate).  The digested peptides from each experiment, and a pool sample, were 
differentially labelled using TMT10-plex reagent (Thermo Scientific).  Fully labelled samples were 
mixed in equal amount and desalted using a 100 mg Sep Pak C18 reverse phase solid-phase extraction 
cartridges (Waters). 
LC/MS/MS protocol 
We analysed three different experimental conditions.  For each condition we analysed 3 biological 
replicates, which were labelled with nine tags of the TMT 10plex.  The remaining TMT tag was used 
to label a pool generated by mixing equal amounts of each sample and it was used to normalise the 
data using the internal reference scaling method (Plubell, Wilmarth et al., 2017).   
TMT-labelled peptides were analysed as previously described (van der Reest et al., 2018) with minor 
modifications. First peptides were fractionated using high pH reverse phase chromatography on a C18 
column (150 × 2.1 mm i.d. - Kinetex EVO (5 μm, 100 Å)) on a HPLC system (Agilent, LC 1260 
Infinity II, Agilent).  A two-step gradient was applied, from 1–28% B in 42 min, then from 28–46% B 
in 13 min to obtain a total of 21 fractions for LC/MS/MS analysis.   
Fractionated peptides were separated by nanoscale C18 reverse-phase liquid chromatography using an 
EASY-nLC II 1200 (Thermo Scientific) coupled to an Orbitrap Fusion Lumos mass spectrometer 
(Thermo Scientific).  Elution was carried out using a binary gradient with buffer A (2% acetonitrile) 
and B (80% acetonitrile), both containing 0.1% formic acid.  Samples were loaded with 6 µl of buffer 
A into a 50 cm fused silica emitter (New Objective) packed in-house with ReproSil-Pur C18-AQ, 
1.9 μm resin (Dr Maisch GmbH).  Packed emitter was kept at 50 °C by means of a column oven 
(Sonation) integrated into the nanoelectrospray ion source (Thermo Scientific).  Peptides were eluted 
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at a flow rate of 300  nl/min using different gradients optimised for three sets of fractions: 1–7, 8–15, 
and 16–21.  Initial percentage of buffer B (%B) was kept constant for 3 minutes, then a two-step 
gradient was used, all with 113 min for step one and 37 min for step two.  The %B were changed as 
follows.  For F1-7, %B was 2 at the start, 17 at step one, and 26 at step two.  For F8-14, %B was 4 at 
the start, 23 at step one, and 35 at step two.  For F15-21, %B was 6 at the start, 27 at step one, and 43 
at step two.  All gradients were followed by a washing step (95% B) of 10 min followed by a 5 min 
re-equilibration step at the initial %B of each gradient, for a total gradient time of 168 min.  Eluting 
peptides were electrosprayed into the mass spectrometer using a nanoelectrospray ion source (Thermo 
Scientific).  An Active Background Ion Reduction Device (ESI Source Solutions) was used to 
decrease air contaminants signal level.  The Xcalibur software (Thermo Scientific) was used for data 
acquisition.  A full scan over mass range of 350–1400 m/z was acquired at 60,000 resolution at 200 
m/z, with a target value of 500,000 ions for a maximum injection time of 20 ms.  Higher energy 
collisional dissociation fragmentation was performed on the 15 most intense ions, selected through an 
isolation window of 0.8 m/z, for a maximum injection time of 100 ms, or a target value of 100,000 
ions. Peptide fragments were analysed in the Orbitrap at 50,000 resolution. 
MS Data Analysis 
The MS Raw data were processed with MaxQuant software (Cox & Mann, 2008) version 1.6.3.3 and 
searched with Andromeda search engine (Cox, Neuhauser et al., 2011), querying SwissProt (UniProt, 
2010).  First and main searches were performed with precursor mass tolerances of 20 ppm and 
4.5 ppm, respectively, and MS/MS tolerance of 20 ppm.  The minimum peptide length was set to six 
amino acids and specificity for trypsin cleavage was required, allowing up to two missed cleavage 
sites.  MaxQuant was set to quantify on “Reporter ion MS2”, and TMT10plex was chosen as Isobaric 
label.  Interference between TMT channels were corrected by MaxQuant using the correction factors 
provided by the manufacturer.  The “Filter by PIF” option was activated and a “Reporter ion 
tolerance” of 0.003 Da was used.  Modification by light (H(3)NOC(2)) and heavy (HNOCx(2)Hx(2)) 
iodoacetamide on cysteine residues (carbamidomethylation) were specified as variable, as well as 
methionine oxidation and N-terminal acetylation modifications, no fixed modifications were 
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specified.  The peptide, protein, and site false discovery rate (FDR) was set to 1 %.  MaxQuant 
outputs were analysed with Perseus software version 1.6.2.3 (Cox & Mann, 2008).  The MaxQuant 
output ModSpecPeptide.txt file was used for quantification of cysteine-containing peptides oxidation, 
whereas ProteinGroup.txt file was used for protein quantification analysis.  Peptides with Cys count 
lower than one were excluded from the analysis, together with Reverse and Potential Contaminant 
flagged peptides.  From the ProteinGroups.txt file, Reverse and Potential Contaminant flagged 
proteins were removed, as well as protein groups identified with no unique peptides.  The TMT 
corrected intensities of proteins and peptides were normalised to the median of all intensities 
measured in each replicate.  Only cysteine-containing peptides uniquely assigned to one protein group 
within each replicate experiment, and robustly quantified in three out of three replicate experiments, 
were normalised to the total protein levels and included in the analysis.  To determine significantly 
regulated cysteine-containing peptides, a Student t-test with a 5% FDR (permutation-based) was 
applied using normalised reporter ions intensities. 
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Figures 
 
 
Figure 1: The reduction of ER-localised disulfides by TCEP requires a membrane component 
(A and B): A stable cell-line expressing ER-SFGFP-iE was evaluated by live-cell imaging and was 
responsive to gross changes in redox conditions.  (A) Depicts fluorescent images of untreated, 
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diamide (1 mM) or DTT-treated (10 mM) cells.  Fluorescence ratio changes are visualised using false 
colours with a more reducing ratio in blue and a more oxidising in yellow.  (B) Normalised 
fluorescent ratios of individual cells (n = 37) are averaged (mean +/- s.d.) and changes observed over 
time by the sequential addition of diamide (1 mM) and DTT (10 mM). 
(C) Normalised fluorescence ratio changes in microsomal membranes isolated from the ER-SFGFP-iE 
expressing cell-line followed using a plate reader.  An increase in ratio is seen following diamide (1 
mM) addition whereas a decrease is seen following DTT (1 mM) addition.  The ER-SFGFP-iE in 
untreated cells is, therefore, neither fully oxidised nor reduced.  The experiment was repeated four 
times (n=5). 
(D) Changes in normalised fluorescence ratio following the addition of impermeable TCEP in the 
absence (blue) or presence (black) of Triton X-100 (0.1 % v/v).  After 35 min Triton X-100 was 
added (0.1 % v/v) to solubilise the intact microsomes.  Note the slower rate of reduction and the lack 
of full reduction with TCEP unless the membranes are solubilised.  The experiment was repeated 
twice (n=3). 
(E) The ER-SFGFP-iE is reduced by TCEP immobilised on agarose beads further confirming that the 
reduction is not direct.  The experiment was carried out in triplicate with average (mean +/- s.d.) 
indicated for untreated (UT), buffer preincubated with TCEP beads (wash) and TCEP beads (beads).   
(F-I) The change in normalised fluorescent ratio was followed at various TCEP concentrations as 
indicated either without (F) or with (H) detergent solubilisation of microsomes.  The rate of reduction 
at each TECP concentration was calculated in triplicate with the average (mean +/- s.d.) plotted vs the 
TCEP concentration (G and I).   
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Figure 2: Thioredoxin-dependent reduction of ER-localised disulfides 
(A) The redox status of Trx1 (trx) was determined by AMS differential alkylation either before (lane 
1) or after (lane 2) incubation with TrxR1 and a NADPH recycling system (C).  Samples not treated 
with AMS are shown in lanes 3 and 4.  The experiment was carried out once.   
(B) The normalised fluorescence ratio of ER-SFGFP-iE was measured following incubation with the 
reduction system without Trx1 (C-Trx) or with the TrxR1 system containing wild type Trx1 (CXXC) 
or active site mutants CXXS or SXXS.  The experiment was repeated twice (n=3) with the average 
(mean +/- s.d.) presented.   
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Figure 3: Thioredoxin-dependent reduction of ERp57 requires a membrane protein.   
(A) The redox status of ER-localised ERp57 was determined following differential alkylation with 
AMS.  (i) in untreated SP-cells, ERp57 exists as a mixture of reduced and oxidised forms (lane 1) and 
becomes fully oxidised (lane 2) or fully reduced (lane 3) following the addition of diamide or DTT 
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respectively.  Partial reduction of ERp57 also occurs following incubation of fully oxidised ERp57 
with the membrane impermeable reductant TCEP (lane 4).  (ii) quantification of the fraction reduced 
in untreated SP-cells (UT), SP-cells treated with diamide (Dia), DTT or TCEP (mean +/- s.d.).  The 
experiment was repeated twice (n=3).   
(B) Thioredoxin-dependent reduction of ER-localised ERp57.  (i) SP-cells were treated with diamide 
before incubation with either the complete TrxR1 reduction system with (C - lane 3) or without (C – 
Trx, lane 5) or with Trx1 alone (lane 4).  ERp57 was partially reduced only by the complete system. 
(ii) quantification of the fraction reduced in SP-cells treated with diamide (Dia), DTT, thioredoxin 
(trx) or a TrxR1 reduction system with (C) or without (C – trx) thioredoxin (mean +/- s.d.).  The 
experiment was repeated twice (n=3).   
(C) The reduction of ERp57 by the TrxR1 system needs Trx1 with an intact active site.  (i) Neither of 
the active site mutants CXXS (lane 4) or SXXS (lane 5) can substitute for wild type (CXXC) Trx1.  
(ii) quantification of the fraction reduced in SP-cells treated with diamide (Dia), DTT, wild type 
(CXXC) or active site mutants (CXXS or SXXS) of thioredoxin (mean +/- s.d.).  The experiment was 
repeated twice (n=3).   
(D) (i) The reduction of ER-localised ERp57 by the TrxR1 system is sensitive to prior treatment of the 
SP-cells with proteinase K (lane 4). (ii) quantification of the fraction reduced in SP-cells treated with 
diamide (Dia), DTT, or a TrxR1 reduction system before (C) or after treatment of the SP-cells with 
proteinase K (prot K) (mean +/- s.d.).  The experiment was repeated twice (n=3).   
(E) (i) The reduction of ER-localised ERp57 by TCEP is not prevented by prior treatment of the SP-
cells with proteinase K (lane 4).  (ii) quantification of the fraction reduced in SP-cells treated with 
proteinase K in the absence of further treatment (UT) or after treatment with diamide (Dia), DTT or 
TCEP (mean +/- s.d.).  The experiment was repeated twice (n=3).   
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Figure 4: Thioredoxin-dependent post-translational rearrangement of ER-localised nascent 
chain disulfides 
(A) Cartoon depicting the rearrangement of nascent chain disulfides in a stalled translocation 
intermediate following the addition of a cytosol-localised reduction system. 
(B) Schematic of the disulfide pattern within the disintegrin domain of ADAM10.  The stalled 
intermediate used in subsequent experiments will have the indicated disulfide-forming cysteines in the 
ER lumen.   
(C) Translations carried out in the presence of DTT (5 mM) gave rise to distinct translation products 
which migrate with the sizes of the pre and mature protein as indicated (lane 1).  Translation were 
carried out in the absence of added G6P and SP-cells subsequently incubated post-translationally in a 
reticulocyte lysate (RRL) in the absence (lane 2) or presence (lane 3) of G6P.  SP-cells were isolated 
from the translations and resuspended in KHM buffer alone (- C) (lane 4).  Note the rearrangement of 
nascent chain disulfides when the TrxR1 system is included in the incubation (lane 5) (+ C) and the 
dependence of this rearrangement on the presence of Trx1 (lane 6) (C - T).  The experiment was 
repeated once (n=2) 
(D) Similarly to the TrxR1 system, TCEP brings about the rearrangement of nascent chain disulfides 
when added to SP-cells post-translationally either in the presence of the rabbit reticulocyte lysate 
(lane 3) or in KHM buffer alone (lane 5).  The experiment was repeated once (n=2).  
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Figure 5: Evaluation of the changes in the redox status of microsomal proteins following 
incubation with the TrxR1 system. 
(A) Volcano plot depicting proteins with significant changes to their redox status where the modified 
cysteines is localised to the ER (blue) or the cytosol (orange).  Proteins identified by mass 
spectrometry whose redox status does not change significantly are also indicated (grey).   
(B) Cartoon illustrating the final cellular location of proteins whose redox status changes significantly 
upon incubation of microsomes with the TrxR1 system.  Proteins that enter the secretory pathway are 
in blue whereas those that do not enter the ER are in orange.  Proteins that become more reduced are 
in normal text, those that become more oxidised are in italics.  Note that PBXIP1 associates with the 
cytoskeleton and is mainly in the cytosol but it does shuttle to the nucleus to act in addition to its role 
as a soluble transcription factor (Abramovich, Chavez et al., 2002) 
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Table 1: List of proteins showing a significant change to their oxidised thiols along with information on 
their subcellular location, position and identity of the modified cysteine(s). 
Location of cys 
modified 
Gene 
name 
protein 
location 
 
type 
 
Cysteine modified 
 
More 
red/ox 
cytosol GAPDH cytoplasm soluble 152;156 Red 
CCS cytoplasm soluble 227 Red 
WDFY3 cytoplasm soluble 952 Ox 
RPL37A cytoplasm soluble 39;42 Ox 
PBXIP1 nucleus soluble 559;565 Ox 
endomembrane 
system 
COL6A1 ECM soluble 745 Red 
COL6A3 ECM soluble 1823;1824 Red 
EFEMP1 ECM soluble 40;47 Red 
LAMB3 ECM soluble 451;453;511;534;536 Red 
LAMC1 ECM soluble 416;418;474;751;804;807;954; 
956 
Ox 
LAMC2 ECM soluble 28;30;53;56 Red 
MMP9 ECM soluble 256 Red 
CALR ER soluble 105 Red 
ERO1L ER  soluble 131 Red 
PLOD1 ER  soluble 267;270 Red 
POFUT1 ER  soluble 283 Red 
TMX2 ER single-pass 59 Red 
GPAA1 ER multi-pass 266 Red 
VKORC1L1 ER multi-pass 50 Red 
LMAN1 ER/Golgi single-pass 230 Red 
LOXL2 ER/secreted soluble 395 Red 
PRDX6 lysosomal soluble 47 Ox 
LAMP1 lysosomal single-pass 338 Ox 
CTSA lysosomal soluble 239 Red 
IGF2R lysosomal soluble 1227 Red 
CTSB lysosomal soluble 211 Red 
KIDINS220 endosome  multi-pass 705 Red 
CD59 PM GPI-anchored 70 Red 
CPD PM single-pass 309 Red 
MFI2 PM GPI-anchored 199 Red 
MGAT5 PM single-pass 338 Ox 
NOTCH2 PM single-pass 1342;1346 Red 
PLXNA1 PM single-pass 358 Red 
AGRN PM/secreted soluble 650 Red 
CYR61 secreted soluble 337;314;317 Red 
ENDOD1 secreted soluble 34 Red 
FN1 secreted soluble 87;97;135;141;179;231;508 Red 
IGFBP7 secreted soluble 156 Ox 
PLAT secreted soluble 419 Red 
PLAU secreted soluble 45 Red 
PSAP secreted soluble 42 Red 
SPARC secreted soluble 130 Red 
STC1 secreted soluble 170 Red 
VEGFC secreted soluble 328 Red 
mitochondrion NDUFA8 mitochondrion soluble 66 Red 
COA6 mitochondrion soluble 44 Red 
Unknown NUMB membrane unknown 130;132 Ox 
DPY19L1 Unknown multi-pass 647 Ox 
Key: ECM; extracellular matrix, PM; plasma membrane, Ox; oxidised, Red; reduced. 
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